Acorda was up 10% early yesterday on the posting of late-stage data for certain Parkinson’s patients, but then fell during the day.
Francis Collins remains NIH chief, but billions of dollars in cuts could be on the way.
Neoantigen-based cancer vaccines represent new, truly personalized therapeutic approaches to treating cancer.
The CEO of Akari Therapeutics has quit amid a probe into the release of phase 2 data and a related analyst report.
Sunovion released some devastating news ahead of the holiday weekend, as the FDA threw a spanner into its plans to bring a new drug for chronic obstructive…
How PAREXEL's New Ecosystem of Technology, Processes and Expertise is Transforming Drug Development
Kite Pharma has secured a priority review at the FDA for its CAR-T candidate.
Scott Gottlieb, M.D., has ended the hiring freeze President Donald Trump imposed on the FDA.
GW Pharma's cannabis-based epilepsy treatment Epidiolex is firmly on track for a filing in the U.S. after new data published in the New England Journal of…
A panel of experts voted 12 to 4 in favor of approving Puma's breast cancer adjuvant therapy neratinib.
Cel-Sci’s pitch to get a partial clinical hold lifted by the FDA has gone awry.
President Donald Trump’s administration has released a breakdown of its attempts to cut back on healthcare and research spending across the government, with…